000100.KS
Yuhan Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 81,400.00
+0.12%Margins
Gross margin
34.3%
EBITDA margin
9.6%
EBIT margin
5.5%
Net margin
10.4%
FCF margin
0.6%
9.9%
Return on equity
7.1%
Return on assets
4.6%
Return on invested capital
0.69x
Asset turnover
KRW 165.7B
Cash from operations
KRW 5.6K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026